MedPath

To Study the Effect of Magnetic Activated Sperm Sorting on the Outcome of in Vitro Fertilization-embryo Transplantation

Not Applicable
Conditions
Infertility, Male
Registration Number
NCT03968367
Lead Sponsor
Li-jun Ding
Brief Summary

Recent studies have evaluated the use of magnetic-activated sperm sorting (MASS) to reduce apoptotic spermatozoa and improve the outcome of infertile male with assisted reproductive technology (ART). However, some results were inconsistent with above. The sperm of male with abnormal semen analysis tend to be accompanied with high apoptotic and high DNA fragmentation index (DFI). Hence, this study aimed at determining the efficiency of MASS in improving the clinical outcome of patients with high DFI).

Detailed Description

Patients will be recruited from our reproductive medicine center in Nanjing Drum towel Hospital, from July 2019 to July 2020. After semen analysis and selection of infertile men with at least two abnormal sperm parameters and obtaining the informed consent of the patients according to the admission criteria, the patients who enter the project will be randomly divided into the control group (n=30) whose sperm will be screened by density differential centrifugation (DGC) with swim up, and the observation group will be screened by MASS, followed by DGC. Then the procedure of in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) will be performed. Embryo transfer will be underwent according to the developmental speed and morphological characteristics of the embryo. The clinical outcomes after transplantation will be followed up.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
60
Inclusion Criteria
  • Patients were diagnostic as infertile according to 2007 WHO guidelines;
  • DFI>25%.
Exclusion Criteria
  • With obvious female infertile factors;
  • Sperm count <10 million;
  • Chromosomal abnormalities in either or both of the couple;
  • Loss of follow up or incomplete information of patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Live-birth rate1year

Live birth rate was defined as the number of deliveries that resulted in a live born neonate.

Pregnancy rate2-3 months

Pregnancy rate was defined from posi tive blood HCG and ultrasonography findings showing at least one embryo with a foetal heart beat 5 weeks after transfer.

Implantation rate2-3 months

Implantation rate means the percentage of those embryos that implanted themselves into the uterine lining after having been transferred to the womb. Fetal heartbeat can be visualized via ultrasound in order to definitely confirm the implantation of the embryo.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School

🇨🇳

Nanjing, Jiangsu, China

Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School
🇨🇳Nanjing, Jiangsu, China
Haixiang Sun
Contact
+86 25 8310 7188
stevensunz@163.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.